Michael Petusky

Stock Analyst at Barrington Research

(0)
# 4311
Out of 5,291 analysts
190
Total ratings
36.08%
Success rate
-11.84%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
Anika Therapeutics
Maintains: Outperform
25 20
15.16 31.93% 16 Mar 13, 2025
OPKO Health
Maintains: Outperform
3 3
1.71 31.58% 11 Mar 12, 2025
VerifyMe
Maintains: Outperform
2 2
0.67 86.57% 9 Mar 7, 2025
ModivCare
Maintains: Outperform
10 6
1.4 328.57% 14 Mar 7, 2025
Dentsply Sirona
Maintains: Outperform
24 20
14.95 33.78% 18 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
108 98
71.86 36.38% 22 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 9 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 38
34.7 9.51% 13 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 111
103.96 6.77% 18 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 90
68.59 31.21% 13 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
108 95
63.01 50.77% 23 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 12
n/a n/a 6 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Jun 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 11, 2016